A new HPRA Innovation Office has been set up to support the development of novel health products and technologies.
For further details see: https://www.hpra.ie/homepage/medicines/news-events/item?t=/new-hpra-innovation-office-to-support-the-development-of-novel-health-products-and-technologies&id=037c0726-9782-6eee-9b55-ff00008c97d0
PIER members are welcome to attend the 'Biosimilars 360 Symposium'in Royal College of Physicians, Kildare Street, Dublin on Saturday 12th Nov 2016 (10am-4pm). See invitation biosimilars-symposium_invitation_12-nov-2016.
The objectives of this symposium are to provide participants with an up-to-date review of the most recent and clinically relevant developments in research, authorisation, regulation, real world evidence/practice, pharmacoeconomics, clinical therapeutic management and the patient’s perspective of biosimilars.
The agenda includes both national and international speakers, most notably from the HPRA, the Norwegian Medicines Agency, NOR-SWITCH overview of results, the patient’s perspective - IPPOSI, a Health & Value perspective, and a case study on a switch study in Southampton University Trust Hospitals.
Further details about the symposium (agenda, speakers etc.) are available through the website www.biosimilars360.ie.Registration is free.
If you have any questions, feel free to contact PIER Member Ed McGettrick who involved in organising this event on firstname.lastname@example.org or 01 4676500.
Following on from our AGM last Saturday 22nd Oct 2016, PIER Committee is delighted to welcome Barry O'Hea (Leo Pharma) to the committee.
We thank Michael Lennon (Jazz Pharmaceuticals) for all his hard work on the committee especially around communications over the past two years.
Pharmacists who hold a Certificate of Registration expiring 31 December 2016 who wish to continue their registration for 2017 may apply online from Wednesday 19th October 2016.
The PSI is no longer issuing hard copy registration renewal forms. Each registered pharmacist will be receiving an email in the near future outlining the options to either apply online or to download the application form for completion. It is important to note that failure to renew 30 days before the expiry of your current certificate will incur the addition of a late fee to continue registration fee.
The latest edition of the European Industrial Pharmacy Journal (Issue 30) is now available eipg-journal-no-30_oct-2016. This issue includes articles antibiotic resistance and a very interesting look forward to how pharmacy will be practiced in 2050.
The PIER Committee is delighted to have PIER member Dr. Dairine Dempsey (Vice President, Strategic Regulatory Affairs, ICON) present on the topic of 'Adaptive Pathways in Medicines Licensing' on Thurs 24th November 2016 at 8am.
Access details will be provided closer to the webinar date.
The NFQ level 9 Postgraduate Certificate in (Bio)Pharma Processing is an innovative programme offered to science, engineering and pharmacy graduates who wish to take up employment in the Irish (Bio)Pharma sector. The programme commencing in September 2016 will be taught over two semesters (September to December and January to April). The programme is part-time and will be taught via a combination of classroom and laboratory classes delivered Fridays (9.30am to 4.30pm) in the School of Pharmacy, UCC and the provision of course materials that students can study under their own schedule at home.
This programme provides an excellent opportunity to obtain an overview of the theory and practical elements of the pharmaceutical and biopharma production of medicines. In addition to technical readiness for employment, the certificate is designed to support participants with job readiness. The module ‘Transitioning into the Workplace’ (5 ECTS) is designed to assist students in actively planning and preparing for their future careers and support students in their application for placements and positions within the (Bio)Pharma sector.
Participants of the previous delivery of this programme 2015/2016 are now employed in technical roles in GSK, Merck Millipore, Boston Scientific and Biomarin.
Should you have any queries about this programme, please do not hesitate to contact Dr. Abina Crean on 021-4901667 or email@example.com. For further programme details, please see https://www.ucc.ie/en/ace-pcbpp/ and attached flyer.